Buyout proposal falls through while dividends continue

Sazerac Company cancelled its proposed US$32 per share, roughly US$15b cash acquisition of Brown-Forman (BF.B) on July 26, 2026, after Brown family interests deemed the offer misaligned with their long term vision.

Brown-Forman shares now trade at US$28.38, with a 1 month share price return of 10.21% and year to date gain of 8.57%. However, the 1 year total shareholder return has declined 3.81% and the 3 year total shareholder return has fallen 56.65%, which points to recent momentum building after a much weaker longer term experience.

If this takeover setback has you reassessing your watchlist, it could be a good moment to look at other consumer brands and broaden your search with the 22 top founder-led companies

Brown-Forman looks like a solid beverage business, and the rejected US$32 offer underlines that. After the share price jump to US$28.38, the next step is to see how that quality lines up with today's valuation.

Most Popular Narrative: 1% Overvalued

The most followed narrative currently places Brown-Forman's fair value at $28.03, slightly below the latest close at $28.38, which creates a very tight valuation gap and puts the focus squarely on execution.

The analysts have a consensus price target of $28.02 for Brown-Forman based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $37.0, and the most bearish reporting a price target of just $20.0.

Want to see what is really driving that fair value call? The narrative points to modest revenue progress, steadier margins, and a future earnings multiple that carries a significant portion of the valuation case.

Result: Fair Value of $28.03 (OVERVALUED)

However, Brown-Forman still faces softer spirits demand and cost pressure, and any deeper pullback in key developed markets could quickly challenge that tight valuation story.

Another View: Brown-Forman Through The DCF Lens

The most followed narrative sees Brown-Forman as about 1% overvalued at $28.38 versus a $28.03 fair value. Our DCF model presents an alternative perspective. It points to a future cash flow value of $38.67 per share, which is 26.6% above the current price and frames the stock as undervalued. That raises a simple question for you as an investor: Which set of assumptions feels more realistic?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Brown-Forman for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Brown-Forman sentiment this finely balanced, it makes sense to move quickly and stress test the story against your own expectations and risk tolerance. To weigh up both the potential upsides and the issues investors are watching, start with the 3 key rewards and 1 important warning sign

Looking for more Brown-Forman investment ideas?

Now that you have a clearer view on Brown-Forman, keep your edge by lining up a few alternative ideas before the next big move catches you off guard.

• Target resilient cash generators and check out companies flagged in the solid balance sheet and fundamentals stocks screener (50 results) to see which stocks pair sturdy finances with dependable business models.
• Hunt for potential mispricings by reviewing the 51 high quality undervalued stocks and spot stocks that combine quality fundamentals with prices that may not fully reflect their strengths.
• Get ahead of the crowd and scan the screener containing 17 high quality undiscovered gems to find lesser known stocks with solid numbers before other investors turn their attention there.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.